JP2021536472A5 - - Google Patents
Info
- Publication number
- JP2021536472A5 JP2021536472A5 JP2021512682A JP2021512682A JP2021536472A5 JP 2021536472 A5 JP2021536472 A5 JP 2021536472A5 JP 2021512682 A JP2021512682 A JP 2021512682A JP 2021512682 A JP2021512682 A JP 2021512682A JP 2021536472 A5 JP2021536472 A5 JP 2021536472A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- compound
- formula
- dithiol
- cyclodextrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862727691P | 2018-09-06 | 2018-09-06 | |
| EP18306172.0 | 2018-09-06 | ||
| US62/727,691 | 2018-09-06 | ||
| EP18306172 | 2018-09-06 | ||
| PCT/EP2019/073873 WO2020049166A1 (en) | 2018-09-06 | 2019-09-06 | Pharmaceutical composition comprising cyclodextrin compexes of anethole trithione or derivatives thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021536472A JP2021536472A (ja) | 2021-12-27 |
| JP2021536472A5 true JP2021536472A5 (enExample) | 2022-09-15 |
| JP7362725B2 JP7362725B2 (ja) | 2023-10-17 |
Family
ID=67841092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021512682A Active JP7362725B2 (ja) | 2018-09-06 | 2019-09-06 | アネトールトリチオンおよびその誘導体のシクロデキストリン複合体を含む医薬組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12295969B2 (enExample) |
| EP (1) | EP3846856A1 (enExample) |
| JP (1) | JP7362725B2 (enExample) |
| KR (1) | KR20210054540A (enExample) |
| CN (1) | CN113038969A (enExample) |
| AU (2) | AU2019336943A1 (enExample) |
| BR (1) | BR112021003997A2 (enExample) |
| CA (1) | CA3111886A1 (enExample) |
| IL (1) | IL281161B2 (enExample) |
| MX (1) | MX2021002611A (enExample) |
| WO (1) | WO2020049166A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022123038A1 (en) * | 2020-12-10 | 2022-06-16 | OP2 Drugs | Anethole trithione administration regimen for the prevention or treatment of ischemia-reperfusion injuries |
| EP4112051A1 (en) * | 2021-06-30 | 2023-01-04 | Op2 Drugs | Anethole trithione for the treatment of vasculitides |
| CN114558004B (zh) * | 2022-03-29 | 2023-08-11 | 奎马特里克斯有限公司 | Qtx125药物制剂 |
| CN115738757B (zh) * | 2022-11-24 | 2024-03-29 | 中国海洋大学 | 一种基于磺丁基-β-环糊精离子传输通道的单价阳离子选择性分离膜及其制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5262165A (en) | 1992-02-04 | 1993-11-16 | Schering Corporation | Transdermal nitroglycerin patch with penetration enhancers |
| US6010715A (en) | 1992-04-01 | 2000-01-04 | Bertek, Inc. | Transdermal patch incorporating a polymer film incorporated with an active agent |
| DK0836506T4 (da) | 1995-06-07 | 2012-01-30 | Ortho Mcneil Pharm Inc | Transdermalt plaster til indgivelse af 17-deacetyl norgestimat alene eller i kombination med et østrogen |
| WO1998027970A2 (en) * | 1996-12-24 | 1998-07-02 | National Research Council Of Canada | Treatment of diseases or prevention of cellular damage caused by oxygen-containing free radicals |
| US5948433A (en) | 1997-08-21 | 1999-09-07 | Bertek, Inc. | Transdermal patch |
| CN1771938A (zh) | 2004-11-09 | 2006-05-17 | 胡才忠 | 茴三硫脂质体及其制备方法 |
| KR20180049019A (ko) * | 2015-09-08 | 2018-05-10 | 오피2 드러그스 | 미토콘드리아의 반응성 산소 종 (ros) 생성과 관련된 질환 치료용 화합물 |
| BR112018004518A2 (pt) * | 2015-09-08 | 2019-03-19 | OP2 Drugs | compostos para o tratamento de doenças ligadas à produção de espécies reativas de oxigênio (ros) mitocondriais |
| CN110662535A (zh) * | 2017-03-07 | 2020-01-07 | Op2药品公司 | 用于治疗与线粒体活性氧(ros)产生相关的疾病的去甲基茴三硫衍生物 |
-
2019
- 2019-09-06 JP JP2021512682A patent/JP7362725B2/ja active Active
- 2019-09-06 US US17/273,928 patent/US12295969B2/en active Active
- 2019-09-06 CN CN201980072663.5A patent/CN113038969A/zh active Pending
- 2019-09-06 EP EP19762427.3A patent/EP3846856A1/en active Pending
- 2019-09-06 MX MX2021002611A patent/MX2021002611A/es unknown
- 2019-09-06 KR KR1020217009152A patent/KR20210054540A/ko not_active Ceased
- 2019-09-06 IL IL281161A patent/IL281161B2/en unknown
- 2019-09-06 WO PCT/EP2019/073873 patent/WO2020049166A1/en not_active Ceased
- 2019-09-06 AU AU2019336943A patent/AU2019336943A1/en not_active Abandoned
- 2019-09-06 BR BR112021003997-0A patent/BR112021003997A2/pt unknown
- 2019-09-06 CA CA3111886A patent/CA3111886A1/en active Pending
-
2025
- 2025-06-03 AU AU2025204144A patent/AU2025204144A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI765451B (zh) | 作為erk抑制劑的螺環類化合物及其應用 | |
| CN101142198B (zh) | 用于治疗疾病的异*唑坎布雷它斯丁衍生物 | |
| JP2019518050A5 (enExample) | ||
| JP2019510787A5 (enExample) | ||
| CA2494049A1 (en) | Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof | |
| WO2021017880A1 (zh) | 一类靶向stat3双功能磷酸化位点的三芳香环类化合物及其应用 | |
| RU2010145529A (ru) | Композиции гидрофобных производных таксана и их применение | |
| JP2018511647A5 (enExample) | ||
| JP2007504284A5 (enExample) | ||
| JP2005526836A5 (enExample) | ||
| JP2005535731A5 (enExample) | ||
| TWI415613B (zh) | Anti-cancer agent resistance to overcome the agent | |
| KR20110013411A (ko) | (ｆ-19)-표지된 ｌ-글루탐산 및 ｌ-글루타민 유도체 (ⅲ), 그의 용도 및 그의 수득 방법 | |
| JP2022544538A5 (enExample) | ||
| JP2024538730A5 (enExample) | ||
| WO2023038088A1 (ja) | トリスルフィド化合物を用いる、肝細胞増殖因子中のチロシン残基のニトロ化を防止する方法 | |
| CN115397846A (zh) | 疏水性修饰的白蛋白及其制备方法和用途 | |
| KR101536488B1 (ko) | 이미다졸 유도체, 그의 제조 방법 및 용도 | |
| JP2023526490A (ja) | フルオロピロロピリジン系化合物及びその使用 | |
| CN111372939A (zh) | 反式-[四氯双(1h-吲唑)钌(iii)]及其组合物的制备 | |
| CN106798731B (zh) | 一种氟苯尼考可溶性粉的制备方法 | |
| JP2006506389A5 (enExample) | ||
| CN103183722B (zh) | 一种乙二醛酶i抑制剂及其制备方法和医药用途 | |
| JP2004224802A (ja) | 抗菌剤 | |
| FR2803299A1 (fr) | NOUVELLES PYRAZOLO [4,3-e] DIAZEPINES SUBSTITUEES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION |